Kevin C. Wilson, MD
Professor, Medicine
Biography
I have expertise in all aspects of evidence-based medicine. This includes the development and appraisal of performance measures, appraisal of the quality of evidence, formulating and grading recommendations, creating evidence summaries, developing clinical practice guidelines, and performing systematic reviews, pragmatic reviews, and meta-analyses.
Other Positions
- Member, Pulmonary Center, Boston University
Education
- University of Maryland School of Medicine, MD
- University of Maryland, BS
Publications
- Published on 1/1/2024
Shankar DA, Hawkins F, Alysandratos KD, Wilson KC, Walkey AJ, Bosch NA, Law AC. Uptake of Antifibrotics for Patients with Idiopathic Pulmonary Fibrosis: 2016-2022. Ann Am Thorac Soc. 2024 Jan; 21(1):170-173. PMID: 37879035.
Read at: PubMed - Published on 9/15/2023
Luo F, Zhu M, Wilson KC. Adult Interstitial Lung Abnormalities: The New Frontier of Pulmonary Fibrosis. Am J Respir Crit Care Med. 2023 Sep 15; 208(6):651-652. PMID: 37552023.
Read at: PubMed - Published on 7/15/2023
Raghu G, Koziar Vasakova M, Wilson KC. Reply to Dutkiewicz and Mackiewicz. Am J Respir Crit Care Med. 2023 Jul 15; 208(2):214-217. PMID: 36693273.
Read at: PubMed - Published on 6/1/2023
Raghu G, Richeldi L, Thomson CC, Remy-Jardin M, Wilson KC. Reply to Cottin et al., to Johannson et al., to Scholand and Wells, and to Crowley et al. Am J Respir Crit Care Med. 2023 Jun 01; 207(11):1542-1543. PMID: 37130124.
Read at: PubMed - Published on 4/15/2023
Wilson KC. Role of Race in the Interpretation of Pulmonary Function Tests: The American Thoracic Society's Efforts to Mitigate Bias in Its Clinical Guidance. Am J Respir Crit Care Med. 2023 Apr 15; 207(8):961-962. PMID: 36976751.
Read at: PubMed - Published on 3/28/2023
Wilson KC. Role of Race in the Interpretation of Pulmonary Function Tests: ATS' Efforts to Mitigate Bias in Its Clinical Guidance. Am J Respir Crit Care Med. 2023 Mar 28. PMID: 36976751.
Read at: PubMed - Published on 1/1/2023
Wilson KC. Clinical Practice Guideline Methodology: An Evolving Science. Am J Respir Crit Care Med. 2023 Jan 01; 207(1):1-2. PMID: 36067508.
Read at: PubMed - Published on 11/15/2022
Raghu G, Richeldi L, Thomson CC, Remy-Jardin M, Wilson KC. Reply to Moran-Mendoza: Idiopathic Pulmonary Fibrosis Update. Reconciliation with Hypersensitivity Pneumonitis Guidelines Required? Am J Respir Crit Care Med. 2022 Nov 15; 206(10):1298. PMID: 35671482.
Read at: PubMed - Published on 9/8/2022
Wilson KC, Ghazipura M, Hossain T, Feller-Kopman DJ, Herman D, Iyer NP, Jennerich AL, Macrea M, Mularski R, Strange C. The American Thoracic Society Guideline Methodology Training Program. ATS Sch. 2022 Oct; 3(3):379-389. PMID: 36312803.
Read at: PubMed - Published on 8/1/2022
Cottin V, Tomassetti S, Valenzuela C, Walsh SLF, Antoniou KM, Bonella F, Brown KK, Collard HR, Corte TJ, Flaherty KR, Johannson KA, Kolb M, Kreuter M, Inoue Y, Jenkins RG, Lee JS, Lynch DA, Maher TM, Martinez FJ, Molina-Molina M, Myers JL, Nathan SD, Poletti V, Quadrelli S, Raghu G, Rajan SK, Ravaglia C, Remy-Jardin M, Renzoni E, Richeldi LK, Spagnolo P, Troy L, Wijsenbeek M, Wilson KC, Wuyts W, Wells AU, Ryerson CJ. Integrating Clinical Probability into the Diagnostic Approach to Idiopathic Pulmonary Fibrosis: An International Working Group Perspective. Am J Respir Crit Care Med. 2022 08 01; 206(3):247-259. PMID: 35353660.
Read at: PubMed
View 134 more publications: View full profile at BUMC